Dina Jacobs, M.D.
Associate Professor of Neurology at the Hospital of the University of Pennsylvania
Clinical Director, Penn MS and Related Disorders Program , Perelman School of Medicine at the Hospital of the University of Pennsylvania
Director, Community Outreach and Network Development, Penn MS and Related Disorders Program , Perelman School of Medicine at the Hospital of the University of Pennsylvania
Neuroscience MS Disease Team Lead , Penn Medicine
Medical monitor , Penn Medicine Community Vaccine Clinics
Clinical Director, Center for Neuroinflammation and Experimental Therapeutics, Penn Medicine
Neurology Outpatient Director, HUP and PCAM, Penn Medicine
Department: Neurology
Contact information
Department of Neurology
Hospital of the University of Pennsylvania
3400 Spruce Street
3 West Gates Building
Philadelphia, PA 19104
Hospital of the University of Pennsylvania
3400 Spruce Street
3 West Gates Building
Philadelphia, PA 19104
Office: (215) 662-3647
Fax: (215) 349-5579
Fax: (215) 349-5579
Education:
B.A. (Natural Science, Spanish)
University of Pennsylvania , 1990.
M.D.
University of Pennsylvania, 1996.
Permanent linkB.A. (Natural Science, Spanish)
University of Pennsylvania , 1990.
M.D.
University of Pennsylvania, 1996.
Selected Publications
Kakara M, Martinak E, McCormick B, Morales KH, Bogner HR, Jacobs DA, Wolf Tuton L : The Bridging the Gaps program: Three Decades of Collaborative Service-Oriented Learning in the Health Professions. Academic Medicine In press 2023Touil H, Li R, Zuroff L, Moore CS, Healy L, Cignarella F, Piccio L, Ludwin S, Prat A, Gommerman J, Bennett FC, Jacobs D, Benjamins JA, Lisak RP, Antel JP, Bar-Or A: Cross-talk between B cells, microglia and macrophages, and implications to central nervous system compartmentalized inflammation and progressive multiple sclerosis. EBioMedicine (Lancet Discovery Science) 11(96), Sep 2023.
Shinoda K, Li R, Rezk A, Mexhitaj I, Patterson K, Kakara M, Zuroff L, Bennett J, von Budingen HC, Carruthers R, Edwards K, Fallis R, Giacomini P, Greenberg B, Hafler D, Ionete C, Kaunzner U, Lock C, Longbrake E, Pardo G, Piehl F, Weber M, Ziemssen T, Jacobs D, Gelfand J, Cross A, Cameron B, Musch B, Winger R, Jia X, Harp C, Herman A, Bar-Or A.: Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. PNAS 120(3): e2207291120, Jan 2023.
Bar-Or A, Jacobs D, Stelzig L, Kim E, Giardino M, Prieur L, Herman A, Craveiro L, Jones D, Arnold D, Reschly K, Kibiy A, Barry W, McNamara J: Randomized, blinded discontinuation trial of ocrelizumab in early relapsing multiple sclerosis: The Autoimmunity Centers of Excellence AMS05 Study. ECTRIMS, Milan, Italy 2023.
Virupakshaiah A, Gill A, Schoeps V, Wilson E, Wilson J, Jacobs D, Do D, Berger J. : The Effect of Ocrelizumab on anti-JC Virus Antibody Index, B cells and immunoglobulins: a longitudinal study ACTRIMS, San Diego, CA 2023.
Lancet Neurology Editorial Board: Towards equitable access to treatment for multiple sclerosis (Editorial on Committee Report from Multiple Sclerosis International Federation Essential Medicines Panel Recommendations for Essential Medicines for the World Health Organization). The Lancet Neurology 2023.
Radzik AM, Amezcua L, Anderson A, Gilmore S, Ahmad S, Brandstadter R, Fabian M, Graham E, Hodgkinson S, Horton L, Jacobs D, Katz Sand I, Kohli A, Levine L, McLemore M, Okai A, Patel J, Poole S, Riley C, Satyanarayan S, Tardo L, Verter E, Villacorta V, Zimmerman V, Zuroff L, Williams M, Houtchens M, Bove R.: Disparities by Race in Pregnancy Care and Clinical Outcomes in Women with MS: a Diverse, Multicenter Cohort. Neurology In press 2023.
Anderson A, Rowles W, Poole S, Balan A, Bevan C, Brandstadter R, Ciplea A, Cooper J, Fabian M, Hale, T, Jacobs D, Kakara M, Krysko K, Longbrake E, Marcus J, Repovic P, Riley C, Romeo A, Rutatangwa A, West T, Hellwig K, LaHue S, Bove R.: Anti-CD20 monoclonal antibody therapy in postpartum women with neurological conditions. Annals of Clinical and Translational Neurology doi: 10.1002/acn3.51893, 2023.
Multiple Sclerosis International Federation Essential Medicines Panel: Multiple Sclerosis International Federation Essential Medicines List for World Heatlh Organization Special Populations: Pregnancy and Breastfeeding in MS in Low-Resource Settings. World Health Organization International 2023.
Multiple Sclerosis International Federation Essential Medicines Panel: Multiple Sclerosis International Federation Essential Medicines List for World Heatlh Organization Special Populations: Pregnancy and Breastfeeding in MS World Health Organization International 2023.